Interesting new information-thanks for posting.
At
Interesting new information-thanks for posting.
At this time, I bet most who are actually invested believe that more than one "Big Pharma" is now at least aware of IPIX due to both B and K. Are any of those "Big Pharma" companies (how big is big enough?) actively negotiating with IPIX? Doesn't seem so as yet since only the AlfaSigma deal has been announced. But who knows what may be "going on behind the scenes" as was stated. Are some BP's now at least aware of IPIX? Sure seems likely. As per my recent response to petemantx about Jerry Jones vs. big pharma comparison, such large pharma companies probably have to get multiple members of upper level management on the same page about a possible venture as well as answer to shareholders about such decisions which could affect careers. At some point, risk vs. reward probably becomes a very similar issue for such companies as it is for individuals. Every single step forward by IPIX, such as what you presented, would seemingly be likely to cause an exponential increase in outside interest. Throw in the existing AlfaSigma deal with RFR on at least portions of IPIX assets (which such potentially interested BP companies would also be aware of as it is available information) and things could get much more interesting at any time. When is that risk/reward inflection point reached for any interested large company and what would that mean to IPIX? All JM uninformed O of course as no one knows exactly what is happening "behind the scene". When is it no longer "behind the scene" and will a person be in or out whenever what is possible may be announced? I hope everyone who is considering what to do with their hard earned money makes a good decision that benefits them. Not always an easy thing to do.
End of too early in the morning pre-coffee rambling.
Innovation Pharmaceuticals Inc (IPIX) Stock Research Links
Scroll down for more posts ▼
Top 10 Most Recent News Articles
Viking Therapeutics Reveal Surprising Data on VK2735 The latest from Viking Therapeutics' camp is giving obesity some serious food for thought, with new data making waves at the ObesityWeek® 2026 meeting. Their investigational dual agonist, VK2735, seems to be shaking things up, as early phase clinical data shows an impressive 74% of participants managed to improve at...
Continue Reading
Winter RV Trips Just Got Cozier There's nothing quite like hitting the open road in an RV during the winter months. But let's face it, nobody wants to return to a cabin that's as frigid as the great outdoors. Here's where FOGATTI steps up its game with the InstaHeat Ultra 35K RV Furnace. They’ve tinkered with the thermostat to iron out more precise control, just in time...
Continue Reading
Ambrosia's Latest Nonclinical Revelations Ambrosia Biosciences has just thrown out some major bait at ObesityWeek® 2026. The highlight? New nonclinical data profiles for two of their understudy small molecule programs—AMB-895 and AMB-131. It may sound niche, but in this sector, promising data spins heads. Their GLP-1 receptor agonist, AMB-895, and GIP receptor...
Continue Reading
When Tech Meets Trouble: Uber's Data Breach Picture this: the hum of Uber rides weaving through your city, drivers none the wiser that personal info has been pried from the vaults thanks to their tech partner, Fireworks AI. Uber, folks, is in hot water once again. This isn’t just another tech hiccup; it's a legal whirlwind brewing up courtesy of Edelson Lechtzin LLP, a...
Continue Reading
A Legal Quagmire for D-Wave Quantum Investors Securities fraud lawsuits are like light in a dark alley—you need them when the truth's been stashed out of sight, but they illuminate the dirty and damp parts of investment strategies nobody wants to talk about. Right now, D-Wave Quantum Inc. is smack dab in the middle of such litigious action. If you had the misfortune of...
Continue Reading
A New Player in Town: Beef 'O' Brady's Lands in Tuscaloosa Listen up, sports fans and pub grub lovers of Tuscaloosa! Beef 'O' Brady's just kicked down the doors and expanded its reach, opening a location smack on McFarland Boulevard. The place threw open its doors on October 26 and is set to make waves in the local scene, driven by the dedicated hands of Mitul Patel and...
Continue Reading
Revving Up a New Chapter: HONGQI in Venice There's a new player in the European automotive scene, and it's rolling in with more style than a Venetian gondola. HONGQI, a name that's been turning gears in China since '58, is packing its suitcases full of Eastern elegance and landing straight in Venice with the all-electric EHS4. On November 16, the brand is set to unveil...
Continue Reading
Never thought I'd see the day when a cruise ship docking would stir such excitement, but here we are. The Star Princess has made its grand debut at Celebration Key, the latest jewel in Princess Cruises' crown. And they're going all out with Bahamian flair—something about a Junkanoo band and beach art that would make even the crustiest sailor crack a smile. Inaugural Fun...
Continue Reading
Shenzhen's Spotlight Moment at APEC 2026 When Shenzhen announced its promotional video for the 2026 APEC Economic Leaders' Meeting, it wasn't just about standard tourism glitz. This was a show of force, a bold step onto the main stage of global politics and economics. The video's launch wasn’t merely an audio-visual delight—it staked a claim in shaping the future...
Continue Reading
Can GLP-1s Deliver Value at Their Current Price? Alright, folks, here's a real-world gut check from CVS Health. They crunched some numbers using Aetna's anonymized claims data, and the results are eye-opening. These GLP-1s are showing promising health outcomes—lower hospital visits, better clinical results, yada yada. But when it comes to savings, they ain't quite...
Continue Reading
Top 5 Most Recently Viewed Articles
Understanding Current Market Dynamics In recent discussions surrounding economic trends, investors are facing a pivotal moment. Ruchir Sharma has pointed out a significant shift in investor sentiment that may unravel in the near future. As he suggests, there could be a critical demand for higher interest rates or a demonstration of fiscal responsibility, triggering...
Continue Reading
Unpacking the Canada Goose Controversy The luxury outerwear brand Canada Goose is currently weathering a storm of scrutiny tied to how it handled tariffs during a particularly convoluted spell in trade policy. Law firm Edelson Lechtzin LLP has zeroed in on allegations that the company inflated its American pricing to cover tariff costs, never lowering those prices or...
Continue Reading
Teamsters Call for Senate Support on Critical Safety Legislation Bipartisan Legislation Critical to Protecting Good Jobs, Safe Streets Following its advancement from the Colorado State Senate Transportation & Energy Committee, Teamsters are urging lawmakers to rally behind HB 25-1122. This crucial legislation mandates that a trained and licensed human safety operator be...
Continue Reading
Cushman & Wakefield Completes Successful Term Loan Repricing Cushman & Wakefield (NYSE: CWK) has recently announced a significant financial move aimed at optimizing its debt structure. The global commercial real estate services firm successfully completed a repricing of approximately $990 million of its Term Loan, which was issued in January 2023 and is due in 2030. This...
Continue Reading
China's Remarkable Journey Over 75 Years On October 1, 2024, a significant milestone was celebrated—the 75th anniversary of the People's Republic of China (PRC). This event marks not just a passage of time but highlights a transformative journey that the nation has undertaken since its founding. Over these decades, China has evolved profoundly, emerging from its...
Continue Reading